| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.700 | 1.293 | 3.477 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 1.737 | 1.293 | 3.477 | 0 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.984 | 4.905 | 5.067 | 3.316 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -4.247 | -3.612 | -1.590 | -3.316 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -4.299 | -3.651 | -1.590 | -3.316 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vneco Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 10.881 | 7.860 | 4.987 | 2.125 |
| Current Assets | - | - | - | - | - | - | 24.184 | 23.795 | 25.007 | 21.613 |
| Inventories | - | - | - | - | - | - | 14.505 | 13.464 | 11.477 | 11.413 |
| Receivables | - | - | - | - | - | - | 7.584 | 6.855 | 10.119 | 6.809 |
| Cash | - | - | - | - | - | - | 2.095 | 3.476 | 3.410 | 3.391 |
| Shareholders Funds | - | - | - | - | - | - | -4.259 | -8.372 | -9.937 | -13.197 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 39.323 | 40.027 | 39.930 | 36.935 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Vneco Bio S.r.l.